Capping years of criticism, Purdue Pharma will stop promoting its opioid drugs to doctors
The manufacturer of the powerful painkiller OxyContin announced this week that it will stop promoting its opioid drugs to doctors after years of criticism and mounting lawsuits, some based in part on a Los Angeles Times investigation.
Connecticut-based Purdue Pharma informed its employees that it was cutting its sales force in half, leaving about 200 representatives in the U.S., who no longer will visit doctors' offices to discuss the company's opioid products.
"We have restructured and significantly reduced our commercial operation and will no longer be promoting opioids to prescribers," the company said in a statement. "Going forward, questions and requests for information about our opioid products will be handled through direct communications with ...
You’re reading a preview, subscribe to read more.
Start your free 30 days